945599-50-8 Usage
Description
1H-PYRROLO[2,3-B]PYRIDINE-1-CARBOXYLIC ACID,4-CHLORO-, 1,1-DIMETHYLETHYL ESTER is a pyrrolopyridine derivative that serves as a key building block in the synthesis of pharmaceutical drugs and agrochemicals. It is recognized for its potential therapeutic properties, particularly in treating cancer and autoimmune diseases, due to its ability to inhibit specific enzymes and biological pathways. Its versatile chemical structure makes it a valuable asset in medicinal and pharmaceutical chemistry.
Uses
Used in Pharmaceutical Industry:
1H-PYRROLO[2,3-B]PYRIDINE-1-CARBOXYLIC ACID,4-CHLORO-, 1,1-DIMETHYLETHYL ESTER is used as a key intermediate in the development of novel drugs for the treatment of cancer and autoimmune diseases. Its capacity to inhibit certain enzymes and biological pathways makes it a promising candidate for creating effective therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 1H-PYRROLO[2,3-B]PYRIDINE-1-CARBOXYLIC ACID,4-CHLORO-, 1,1-DIMETHYLETHYL ESTER is utilized as a building block in the synthesis of various agrochemicals, contributing to the development of innovative products for agricultural applications.
Check Digit Verification of cas no
The CAS Registry Mumber 945599-50-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,5,5,9 and 9 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 945599-50:
(8*9)+(7*4)+(6*5)+(5*5)+(4*9)+(3*9)+(2*5)+(1*0)=228
228 % 10 = 8
So 945599-50-8 is a valid CAS Registry Number.
945599-50-8Relevant articles and documents
HETEROCYCLIC COMPOUNDS AND METHODS OF USE
-
Paragraph 000212, (2020/02/06)
The present invention discloses compounds useful in treatment of conditions associated with excessive activity of transforming growth factor beta (TGF-β), particularly type 1 or activin-like kinase 5 (ALK 5). Specifically the present invention discloses compound of formula (I) which exhibit inhibitory activity against ALK 5. Method of treating conditions associated with excessive activity (ALK 5) with such compound is disclosed. Uses thereof, pharmaceutical composition, and kits are also disclosed.